Page last updated: 2024-08-25

budipine and Idiopathic Parkinson Disease

budipine has been researched along with Idiopathic Parkinson Disease in 18 studies

Research

Studies (18)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (16.67)	18.7374
1990's	6 (33.33)	18.2507
2000's	7 (38.89)	29.6817
2010's	2 (11.11)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lettow, I; Röther, J	1
Büttner, T; Csoti, I; Kassubek, J; Reichmann, H; Riederer, P; Schulz, JB; Wüllner, U	1
Ceballos-Baumann, A	1
Kuhn, W; Müller, T; Przuntek, H	1
Ludolph, A; Odin, P; Oehlwein, C; Polzer, U; Renner, R; Schüler, P; Shing, M; Storch, A; Werner, G	1
Reichmann, H	1
Boose, A; Dichgans, J; Jentgens, C; Klockgether, T; Löschmann, P; Spieker, S	1
Klockgether, T; Löschmann, PA; Spieker, S	1
Müller, T; Przuntek, H	1
Breit, S; Dichgans, J; Klockgether, T; Spieker, S	1
Ghaemi, M; Rudolf, J; Schmülling, S	1
Bliesath, H; Böther, K; Lühmann, R; Malsch, U; Ramm, H	1
Müller, T	1
Bittkau, S; Bliesath, H; Büttner, U; Fuchs, G; Glass, J; Haller, H; Klockgether, T; Kraus, P; Lachenmayer, L; Müller, D; Müller, T; Przuntek, H; Rathay, B; Sgonina, J; Steinijans, V; Teshmar, E; Ulm, G; Volc, D	1
Bliesath, H; Jellinger, K	1
Fischer, R; Iizuka, J	1

Reviews

5 review(s) available for budipine and Idiopathic Parkinson Disease

Article	Year
[On the role of MAO B inhibitors and NMDA antagonists in the therapy of Parkinson's disease]. Fortschritte der Neurologie-Psychiatrie, 2010, Volume: 78 Suppl 1 Topics: Amantadine; Excitatory Amino Acid Antagonists; Humans; Indans; Memantine; Monoamine Oxidase; Monoamine Oxidase Inhibitors; N-Methylaspartate; Parkinson Disease; Piperidines; Selegiline	2010
[Diagnosis and treatment of Parkinson's syndrome. What is important for the general practitioner?]. MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2 Topics: Aged; Amantadine; Antiparkinson Agents; Apomorphine; Botulinum Toxins; Catechols; Cholinesterase Inhibitors; Clinical Trials as Topic; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Enzyme Inhibitors; Ergot Alkaloids; Family Practice; Female; Humans; Levodopa; Male; Nitriles; Parkinson Disease; Parkinson Disease, Secondary; Parkinsonian Disorders; Piperidines	2003
Budipine in Parkinson's tremor. Journal of the neurological sciences, 2006, Oct-25, Volume: 248, Issue:1-2 Topics: Animals; Antiparkinson Agents; Humans; Parkinson Disease; Piperidines; Tremor	2006
Clinical efficacy of budipine in Parkinson's disease. Journal of neural transmission. Supplementum, 1999, Volume: 56 Topics: Animals; Antiparkinson Agents; Clinical Trials as Topic; Humans; Parkinson Disease; Piperidines	1999
Non-dopaminergic drug treatment of Parkinson's disease. Expert opinion on pharmacotherapy, 2001, Volume: 2, Issue:4 Topics: Adenosine; Adrenergic alpha-Antagonists; Body Weight; Cholinergic Antagonists; Homocysteine; Humans; Levodopa; Methionine; N-Methylaspartate; Parkinson Disease; Piperidines; Serotonin Receptor Agonists	2001

Trials

9 trial(s) available for budipine and Idiopathic Parkinson Disease

Article	Year
Efficacy of budipine and placebo in untreated patients with Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996), 2005, Volume: 112, Issue:8 Topics: Adult; Aged; Antiparkinson Agents; Basal Ganglia; Disability Evaluation; Dopamine; Double-Blind Method; Female; Humans; Male; Middle Aged; Movement; Neurologic Examination; Parkinson Disease; Piperidines; Placebo Effect; Synaptic Transmission; Treatment Outcome	2005
Efficacy and safety of high-dose cabergoline in Parkinson's disease. Acta neurologica Scandinavica, 2006, Volume: 113, Issue:1 Topics: Adolescent; Adult; Aged; Amantadine; Antiparkinson Agents; Cabergoline; Catechols; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Humans; Levodopa; Middle Aged; Nitriles; Parkinson Disease; Piperidines; Prospective Studies; Quality of Life; Selegiline; Severity of Illness Index; Treatment Outcome	2006
Tremorlytic activity of budipine: a quantitative study with long-term tremor recordings. Clinical neuropharmacology, 1995, Volume: 18, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Electromyography; Female; Humans; Male; Middle Aged; Parkinson Disease; Pilot Projects; Piperidines; Time Factors; Tremor	1995
The NMDA antagonist budipine can alleviate levodopa-induced motor fluctuations. Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:3 Topics: Adult; Aged; Antiparkinson Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; N-Methylaspartate; Parkinson Disease; Pilot Projects; Piperidines; Severity of Illness Index	1999
Tremorlytic activity of budipine in Parkinson's disease. Journal of neural transmission. Supplementum, 1999, Volume: 56 Topics: Aged; Antiparkinson Agents; Double-Blind Method; Electromyography; Female; Humans; Levodopa; Male; Parkinson Disease; Piperidines; Tremor	1999
[Monotherapy of Parkinson's disease with budipine. A double blind comparison with amantadine]. Fortschritte der Neurologie-Psychiatrie, 2001, Volume: 69, Issue:2 Topics: Aged; Aged, 80 and over; Amantadine; Antiparkinson Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease; Piperidines	2001
Budipine provides additional benefit in patients with Parkinson disease receiving a stable optimum dopaminergic drug regimen. Archives of neurology, 2002, Volume: 59, Issue:5 Topics: Adult; Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agents; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piperidines; Treatment Outcome	2002
Adjuvant treatment of Parksinson's disease with budipine: a double-blind trial versus placebo. Journal of neurology, 1987, Volume: 234, Issue:5 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Benserazide; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piperidines	1987
[Modification of Parkinson tremor by budipine. A comparative study with amantadine]. Der Nervenarzt, 1986, Volume: 57, Issue:3 Topics: Adult; Aged; Amantadine; Antiparkinson Agents; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piperidines; Random Allocation	1986

Other Studies

4 other study(ies) available for budipine and Idiopathic Parkinson Disease

Article	Year
[Medical treatment of Parkinson's disease in elderly and multimorbid patients]. Der Internist, 2014, Volume: 55, Issue:6 Topics: Aged, 80 and over; Antiparkinson Agents; Catechol O-Methyltransferase Inhibitors; Cholinergic Antagonists; Dopamine Agonists; Female; Humans; Levodopa; Male; Monoamine Oxidase Inhibitors; Parkinson Disease; Piperidines	2014
[Parkinson diseases--polyvalent therapy with Budipin]. Der Nervenarzt, 1998, Volume: 69, Issue:2 Suppl Mo Topics: Antiparkinson Agents; Humans; Parkinson Disease; Piperidines	1998
Deterioration of parkinsonian symptoms following treatment of dopaminergic hallucinosis with olanzapine. European psychiatry : the journal of the Association of European Psychiatrists, 1999, Volume: 14, Issue:6 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Drug Therapy, Combination; Hallucinations; Humans; Levodopa; Male; Olanzapine; Paranoid Disorders; Parkinson Disease; Piperidines; Pirenzepine; Selegiline; Severity of Illness Index	1999
[Therapeutic effect of budipin in treating Parkinson's disease]. Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry, 1985, Volume: 18, Issue:4 Topics: Antiparkinson Agents; Female; Humans; Male; Middle Aged; Parkinson Disease; Piperidines	1985